Arcus Biosciences, Inc. RCUS
NYSE · United States · Health Technology
$25.48-0.35 (-1.36%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.72 | -0.89 | +19.2% | $41.00M | +86.5% | -1.6%$28.80→$28.33 |
| Q1 2026 | 2026-05-05 | -1.02 | -0.92 | -10.9% | — | — | -0.2% |
| Q4 2025 | 2026-02-25 | -0.89 | -1.11 | +19.8% | — | — | -3.2%$20.19→$19.54 |
| Q3 2025 | 2025-10-28 | -1.27 | -1.33 | +4.5% | — | — | +9.1%$18.60→$20.29 |
| Q4 2024 | 2025-02-25 | -1.03 | -1.20 | +14.2% | — | — | — |
| Q4 2023 | 2024-02-21 | -1.08 | -1.00 | -8.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.